AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...
COLUMBUS, Ohio – Using advanced artificial intelligence, researchers have developed a novel method to make drug development faster and more efficient. DiffSMol works by analyzing the shapes of known ...
While past breakthroughs at Penn have shown that AI can successfully sort through mountains of data to identify promising antibiotic candidates, this study adds to a small but growing number of ...
Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by ...
The collaboration has the power to foster breakthroughs in small molecule innovation for life science-based products REHOVOT, Israel, Oct. 31, 2024 /PRNewswire/ -- Evogene Ltd. (EVGN), a leading ...
After three years of internal development, Expedition is building a generative AI platform for covalent drug discovery, supported by a $50M initial commitment from Flagship Pioneering Multi-target ...
Scientists debut a generative AI model that could create molecules addressing hard-to-treat diseases
More than 300 people across academia and industry spilled into an auditorium to attend a BoltzGen seminar on Thursday, Oct. 30, hosted by the Abdul Latif Jameel Clinic for Machine Learning in Health ...
Researchers at Los Alamos National Laboratory have developed a new approach that addresses the limitations of generative AI ...
The lab of Pranam Chatterjee (pictured), in collaboration with the lab of César de la Fuente, developed and validated a new "diffusion model" that can generate antibiotic candidates the same way AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback